ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,064.20
      0.91%
      US Tech 100
      17,180.80
      0.61%
      Dow Jones
      38,225.66
      0.85%
      Brent Oil
      83.865
      0.28%
      Bitcoin
      58,948.92
      -0.29%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. AN2 Therapeutics Inc (ANTX)

      7. AN2 Therapeutics Inc (ANTX) News

      ANTX AN2 Therapeutics Inc

      2.60
      0.06 (2.36%)
      Pre Market
      Last Updated: 04:33:06
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      AN2 Therapeutics Inc ANTX NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.06 2.36% 2.60 04:33:06
      Open Price Low Price High Price Close Price Prev Close
      2.54
      more quote information »

      Recent News

      Date Time Source Heading
      5/02/202410:07IHNWFeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
      3/28/202416:10BWAN2 Therapeutics Reports Fourth Quarter and Full Year 2023..
      2/13/202417:11EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      2/12/202407:01EDGAR2Form 8-K - Current report
      2/12/202406:45BWAN2 to Voluntarily Pause Enrollment in Phase 3 Part of Phase..
      1/30/202416:10BWAN2 Therapeutics to Present at Oppenheimer Healthcare Life..
      1/18/202418:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/17/202417:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/12/202417:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/11/202419:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/04/202418:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/04/202418:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/02/202416:45EDGAR2Form 144 - Report of proposed sale of securities
      1/02/202416:36EDGAR2Form 144 - Report of proposed sale of securities
      11/16/202318:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/09/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/09/202316:10EDGAR2Form 8-K - Current report
      11/09/202316:05BWAN2 Therapeutics Reports Third Quarter 2023 Financial..
      11/06/202307:00BWAN2 Therapeutics to Present at Upcoming Investor Conferences
      10/18/202307:00BWAN2 Therapeutics Signs License Agreement with the University..
      10/11/202300:01BWAN2 Therapeutics to Present New Data for Epetraborole at..
      10/03/202319:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/02/202316:10EDGAR2Form 144 - Report of proposed sale of securities
      9/29/202317:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/29/202316:11EDGAR2Form 144 - Report of proposed sale of securities
      9/26/202307:00BWAN2 Therapeutics Signs Grant Agreement to Discover Novel,..
      9/15/202317:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/13/202308:00EDGAR2Form 8-K - Current report
      9/13/202307:00BWAN2 Therapeutics commences Phase 3 Part of Phase 2/3..
      9/08/202316:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/25/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/23/202316:14EDGAR2Form 144 - Report of proposed sale of securities
      8/16/202316:50EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      8/16/202316:47EDGAR2Form 8-K - Current report
      8/15/202322:42BWAN2 Therapeutics Announces Pricing of $70.0 Million..
      8/10/202316:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/10/202316:18EDGAR2Form 8-K - Current report
      8/10/202316:10BWAN2 Therapeutics Reports Second Quarter 2023 Financial..
      5/25/202316:10BWAN2 Therapeutics to Present at Jefferies Healthcare..
      5/11/202316:10BWAN2 Therapeutics Reports First Quarter 2023 Financial..

      Your Recent History

      NASDAQ
      ANTX
      AN2 Therapeutics
      Delayed Upgrade Clock